Novel ligand compounds that activate RAR receptors have the following structural formula (I):
and are suited for formulation into pharmaceutical compositions useful in human or veterinary medicine, or, alternatively, into cosmetic compositions.
能激活RAR受体的新型
配体化合物具有以下结构式(I):并适用于制备用于人类或兽医药物的制剂,或者是化妆品制剂。